Mitesco, Biotech Stock Review, roland rick perry

Short Squeeze Mania.

Citius Pharma (CTXR) Locked and Loaded. Truly Locked and Loaded. Latest $20 Million Round is Biggest News We've Seen...

Make Hay While the Sun Shines. Up 6,400%.

Celcius (CELH) We're Up 6,400%. Alkaline Water (WTER) We're Up 12%.Dicerna (DRNA) We're Up 700%. Ready to Breakout?BioSig (BSGM) We Have...
Satori Capital. Hapbee

Investment Manager With $1 Billion in Assets Under Management, Buys 300 Hapbee (HAPB) Head...

Things that make you go mmmm. Randy Eisenman is co-founder and managing partner of Satori Capital with more than...
Hapbee, EMulate, HAPB

A Medical Technology That Has The Highest Potential Over Any We Follow.

You Must Read This... New Report on the People Behind EMulate Therapeutics. 200 Million...
Hapbee

Jim Kwik and Kevin Harrington Join Hapbee Technologies (HAPB) Board.

Hapbee Announces Additions to Advisory Board December 17, 2020 New Advisors Bring Decades of Entrepreneurial ExperienceWellness...
HAPBEE

Hapbee (HAPB): The Netflix of Feelings

After 15 years, $70 million spent on R&D, and 350,000+ hours of testing, this "Netflix of Feelings" wearable technology is finally...
Hapbee, Biotech Stock Review

Scott Donnell Used His Intuition to Launch Hapbee (HAPB). Video.

My next guest, Scott Donnell, who is a serial entrepreneur and CEO of Hapbee (www.hapbee.com), had a knack for business early in...

Dalrada (DFCO) Appoints Gregory L. Remsen To Vice President of Strategic Relationships.

Dalrada Financial Corporation Appoints Gregory L. Remsen To Vice President of Strategic Relationships DALRADA NEWS ARCHIVE
Hapbee

Adding Hapbee (HAPB) to the Watch List.

Listed on TSX under HAPB, we're officially price and time stamping our interest in this amazing little technology Company by adding it...
Hapbee

Hapbee’s (HAPB) Device, “Choose How You Feel.”

HAPBEE ANNOUNCES LAUNCH OF A SUBSCRIPTION-BASED WELLBEING WEARABLE, PROVIDING MEMBERS THE ABILITY TO CHOOSE 'HOW THEY FEEL' Proprietary, Research-Backed...

Latest article

Smart for Life (SMFL) Capitulates?

We Are Long Term Bullish on Smart for Life. After a Volatile Post IPO Trading, we may Have Seen the Bottom....

Althira (ATHA) $2.50, is Latest Alzheimer’s Trial Victim. Down 70%

Nearly 100 Alzheimer’s programs have failed in the past decade. Biotech investors should study or at least become...

Novogratz Remains Steadfast on Crypto, Says Wait Until Next Year (Bloomberg)

Great call. This was actually from Late 2018. (Bloomberg) — Billionaire investor Michael Novogratz is resolute when it...